Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Peng

Showing results (721-730 of 1,000) with videos related to

Pageof 100
Sort By:
JAMA Oncology|July 24, 2020
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy SpecimensKunal Nagpal, Davis Foote, Fraser Tan, et al.
Cancer Cell|December 15, 2023
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinomaYunfan Sun, Pin Wu, Zefan Zhang, et al.
Cancer Research|September 18, 2025
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic CancerYongkun Wei, Minghui Liu, Er-Yen Yen, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancerJiehui Deng, David H Peng, David Fenyo, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRAS <sup>G12D</sup> inhibition in pancreatic ductal adenocarcinomaKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Genetics|October 30, 2004
Chromosome bin map of expressed sequence tags in homoeologous group 1 of hexaploid wheat and homoeology with rice and ArabidopsisJ H Peng, H Zadeh, G R Lazo, et al.
Nature Communications|July 3, 2021
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinomaYun-Fan Sun, Liang Wu, Shi-Ping Liu, et al.
The EMBO Journal|July 11, 2026
CDK8 remodels the tumor microenvironment and promotes resistance to KRAS<sup>G12D</sup> inhibitors and daraxonrasib in PDACKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Molecular Psychiatry|November 6, 2013
Common genetic variants on 1p13.2 associate with risk of autismK Xia, H Guo, Z Hu, et al.
Nature Cancer|August 5, 2024
Co-targeting SOS1 enhances the antitumor effects of KRAS<sup>G12C</sup> inhibitors by addressing intrinsic and acquired resistanceVenu Thatikonda, Hengyu Lyu, Sabine Jurado, et al.
Pageof 100

Showing results (721-730 of 1,000) with videos related to

Sort By:
Pageof 100
JAMA Oncology|July 24, 2020
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy SpecimensKunal Nagpal, Davis Foote, Fraser Tan, et al.
Cancer Cell|December 15, 2023
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinomaYunfan Sun, Pin Wu, Zefan Zhang, et al.
Cancer Research|September 18, 2025
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic CancerYongkun Wei, Minghui Liu, Er-Yen Yen, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancerJiehui Deng, David H Peng, David Fenyo, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRAS <sup>G12D</sup> inhibition in pancreatic ductal adenocarcinomaKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Genetics|October 30, 2004
Chromosome bin map of expressed sequence tags in homoeologous group 1 of hexaploid wheat and homoeology with rice and ArabidopsisJ H Peng, H Zadeh, G R Lazo, et al.
Nature Communications|July 3, 2021
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinomaYun-Fan Sun, Liang Wu, Shi-Ping Liu, et al.
The EMBO Journal|July 11, 2026
CDK8 remodels the tumor microenvironment and promotes resistance to KRAS<sup>G12D</sup> inhibitors and daraxonrasib in PDACKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Molecular Psychiatry|November 6, 2013
Common genetic variants on 1p13.2 associate with risk of autismK Xia, H Guo, Z Hu, et al.
Nature Cancer|August 5, 2024
Co-targeting SOS1 enhances the antitumor effects of KRAS<sup>G12C</sup> inhibitors by addressing intrinsic and acquired resistanceVenu Thatikonda, Hengyu Lyu, Sabine Jurado, et al.
Pageof 100